Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Site Map
2019
December
04
High cost rules out NIPT as 1st test for Down syndrome
Veracyte licenses NanoString diagnostic platform in $50M deal
FDA clears FoundationOne CDx for Piqray in breast cancer
FDA awards $20M to DNAnexus to enhance cloud-based research portal
SiO2 launches unbreakable blood collection tube for genetic diagnostics
Page 1 of 1